News Release Center

FOR IMMEDIATE RELEASE
12/20/2016 12:00:00 AM PACIFIC
Updated: 12/20/2016 9:38:34 AM PACIFIC
For more information, contact Adina Bielenberg.
Gritman offers new prostate test, reducing need for invasive biopsies
The Gritman Medical Center Laboratory is the first laboratory in the Pacific Northwest to offer the non-invasive Prostate Health Index (PHI) test. This innovative blood test is nearly three times more accurate than the current standard prostate-specific antigen (PSA) blood test and addresses many of the drawbacks associated with PSA screenings.
 
In the past, when a standard PSA screenings came back with a PSA level above 4ng/mL, a man’s doctor would often recommend he undergo a prostate biopsy. Thanks to PHI-enhanced specificity for prostate cancer detection, one in three men with high PSA levels can avoid a prostate biopsy and complete a simple PHI blood test instead.
 
Increased PHI scores predict a greater risk of cancer. If PHI scores are increasing over time, the patient has a higher risk of an aggressive cancer and a higher risk of developing cancer after the prostate is removed.
 
The National Comprehensive Cancer Network recommends that PHI testing be preformed to improve cancer detection.
 
To find out more about PHI testing, ask you primary care provider how a simple blood test could prevent a prostate biopsy. For additional information, call the Gritman Laboratory at 208-883-6402.
 

  • News releases main
  • Media contacts
  • News and information
  • News releases archive
  • Filter by category